Hyderabad Telangana, India

Anil Kumar Soni

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: Taxis Pharmaceuticals, Inc., Bausch-Lomb Incorporated. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anil Kumar Soni. Retrieved from https://idiyas.com/inventor/anil-kumar-soni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Anil Kumar Soni: Innovator in Antibacterial Agents

Introduction

Anil Kumar Soni is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of synthetic processes, particularly in the development of antibacterial agents. With a total of four patents to his name, Soni's work has had a meaningful impact on pharmaceutical innovations.

Latest Patents

Among his latest patents, Soni has developed synthetic intermediates and processes that are essential for preparing the antibacterial agent TXA709. This invention showcases his expertise in creating effective solutions for combating bacterial infections.

Career Highlights

Throughout his career, Anil Kumar Soni has worked with reputable companies such as Taxis Pharmaceuticals, Inc. and Bausch & Lomb Incorporated. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Soni has collaborated with talented individuals in his field, including Ravi Ponnaiah and Thrisulapani Korrakuti. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Anil Kumar Soni's contributions to the field of synthetic processes and antibacterial agents highlight his role as a significant inventor. His work continues to influence the pharmaceutical landscape, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…